Leerink Partnrs Has Negative Forecast for ACHC Q1 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities research analysts at Leerink Partnrs cut their Q1 2025 EPS estimates for shares of Acadia Healthcare in a report released on Thursday, January 30th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.66 per share for the quarter, down from their previous estimate of $0.72. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.39 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q2 2025 earnings at $0.85 EPS, Q1 2026 earnings at $0.85 EPS, Q2 2026 earnings at $1.05 EPS, Q3 2026 earnings at $1.10 EPS and Q4 2026 earnings at $0.96 EPS.

A number of other analysts also recently issued reports on the company. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective for the company in a research report on Tuesday, January 7th. Barclays dropped their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, TD Cowen decreased their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Price Performance

ACHC stock opened at $45.11 on Monday. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market cap of $4.19 billion, a price-to-earnings ratio of 14.79, a price-to-earnings-growth ratio of 1.78 and a beta of 1.29. The business has a fifty day moving average of $41.79 and a two-hundred day moving average of $55.52.

Hedge Funds Weigh In On Acadia Healthcare

Several large investors have recently bought and sold shares of ACHC. Bank of Montreal Can raised its stake in Acadia Healthcare by 8.0% during the 2nd quarter. Bank of Montreal Can now owns 12,698 shares of the company’s stock worth $859,000 after acquiring an additional 936 shares in the last quarter. Algert Global LLC purchased a new position in Acadia Healthcare during the 2nd quarter worth approximately $628,000. Sanctuary Advisors LLC acquired a new position in Acadia Healthcare during the second quarter worth approximately $417,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Acadia Healthcare in the second quarter valued at approximately $59,000. Finally, Handelsbanken Fonder AB boosted its holdings in shares of Acadia Healthcare by 21.0% in the third quarter. Handelsbanken Fonder AB now owns 21,874 shares of the company’s stock valued at $1,387,000 after acquiring an additional 3,800 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.